Zoetis.co.uk uses cookies to improve your experience when browsing our website. By continuing to use this site, you are agreeing to their use. To find out more, view our cookie policy.

United Kingdom
Convenia logo

The Right Drug

In a study, SSTI, UTI & PD accounted for 48% of canine cases requiring antibiotics1

The European Dog Antimicrobial Market

The European Dog Antimicrobial Market

Convenia is Highly Efficacious Against A Wide Range of Bacteria

Convenia is Highly Efficacious Against A Wide Range of Bacteria
Click image to enlarge

MIC90 MATTERS!

Key pathogens are highly susceptible to Convenia in vitro2

MIC90 results for key pathogens

MIC90 results for key pathogens
Click image to enlarge

Ensure the pathogen you are treating is susceptible to Convenia; ask us for complimentary sensitivity discs..

REFERENCES
1 PAH GMR FB, Antimicrobials for Pets Annual Study, Bio Sat, July 2009.
2 Stegemann MR et al. 2006. Antimicrob. Agents Chemother; 50(7), 2286-92

It is prudent to reserve 3rd-generation cephalosporins for clinical conditions responding poorly or expected to respond poorly to other classes of antimicrobials or 1st-generation cephalosporins.  Convenia use should be based on susceptibility testing.

Skin and soft tissue infections

Periodontal infections

Urinary Tract infections